Single Ascending-Dose Study of Selective ErbB4 Agonist JK07 in Heart Failure With Reduced Ejection Fraction.

JACC Basic Transl Sci · 2025 · PMC12332861 · PMID 40737710

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The observed long-term (days 90-180) changes in NT-proBNP, which showed a trend toward lower NT-proBNP levels in JK07-treated participants at all dose levels, are difficult to interpret, given the small sample size in this study.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.